Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2014, Article ID 510285, 13 pages
http://dx.doi.org/10.1155/2014/510285
Review Article

Current Treatment Limitations in Age-Related Macular Degeneration and Future Approaches Based on Cell Therapy and Tissue Engineering

1Ophthalmology Experimental Laboratory, School of Medicine, University of Navarra, C/Irunlarrea 1, 31008 Pamplona, Spain
2Tissue Engineering and Biomaterials Unit, CEIT and TECNUN (University of Navarra), Paseo de Manuel Lardizabal 15, 20018 San Sebastian, Spain
3Department of Ophthalmology, RWTH Aachen University Hospital, Pauwelsstraße 30, 52074 Aachen, Germany
4Department of Ophthalmology, Geneva University Hospitals, Faculty of Medicine, University of Geneva, Rue Alcide-Jentzer 22, 1211 Geneve 14, Switzerland
5Department of Functional Materials in Medicine and Dentistry, University of Würzburg, Pleicherwall 2, 97070 Würzburg, Germany
6Department of Ophthalmology, School of Medicine, Clinica Universidad de Navarra, Avenida Pio XII 36, 31008 Pamplona, Spain

Received 26 July 2013; Accepted 10 December 2013; Published 14 January 2014

Academic Editor: Edward Manche

Copyright © 2014 P. Fernández-Robredo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. C. Bird, “Retinal photoreceptor dystrophies Ll. Edward Jackson Memorial Lecture,” American Journal of Ophthalmology, vol. 119, no. 5, pp. 543–562, 1995. View at Google Scholar · View at Scopus
  2. R. Klein, B. E. K. Klein, S. C. Jemen, and K. J. Cruichshanks, “The relationship of ocular factors to the incidence and progression of age-related maculopathy,” Archives of Ophthalmology, vol. 116, no. 4, pp. 506–513, 1998. View at Google Scholar · View at Scopus
  3. A. Banerjee, S. Kumar, P. Kulhara, and A. Gupta, “Prevalence of depression and its effect on disability in patients with age-related macular degeneration,” Indian Journal of Ophthalmology, vol. 56, no. 6, pp. 469–474, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Z. Nowak, “Age-related macular degeneration (AMD): pathogenesis and therapy,” Pharmacological Reports, vol. 58, no. 3, pp. 353–363, 2006. View at Google Scholar · View at Scopus
  5. R. D. Jager, W. F. Mieler, and J. W. Miller, “Age-related macular degeneration,” The New England Journal of Medicine, vol. 358, no. 24, pp. 2544–2617, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. Zarbin, “Current concepts in the pathogenesis of age-related macular degeneration,” Archives of Ophthalmology, vol. 122, no. 4, pp. 598–614, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Buschini, A. Piras, R. Nuzzi, and A. Vercelli, “Age related macular degeneration and drusen: neuroinflammation in the retina,” Progress in Neurobiology, vol. 95, no. 1, pp. 14–25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. L. V. del Priore, T. H. Tezel, and H. J. Kaplan, “Maculoplasty for age-related macular degeneration: reengineering Bruch's membrane and the human macula,” Progress in Retinal and Eye Research, vol. 25, no. 6, pp. 539–562, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. T. H. Tezel, L. V. del Priore, A. S. Berger, and H. J. Kaplan, “Adult retinal pigment epithelial transplantation in exudative age-related macular degeneration,” American Journal of Ophthalmology, vol. 143, no. 4, pp. 584–e2, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. P. Hubschman, S. Reddy, and S. D. Schwartz, “Age-related macular degeneration: current treatments,” Clinical Ophthalmology, vol. 3, no. 1, pp. 155–166, 2009. View at Google Scholar · View at Scopus
  11. “Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group,” Archives of Ophthalmology, vol. 109, no. 9, pp. 1242–1257, 1991. View at Scopus
  12. “Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group,” Archives of Ophthalmology, vol. 111, no. 9, pp. 1200–1209, 1993. View at Scopus
  13. “Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group,” Archives of Ophthalmology, vol. 112, no. 4, pp. 489–499, 1994. View at Scopus
  14. N. M. Bressler, “Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials—TAP report 2,” Archives of Ophthalmology, vol. 119, no. 2, pp. 198–207, 2001. View at Google Scholar · View at Scopus
  15. S. Binder, B. V. Stanzel, I. Krebs, and C. Glittenberg, “Transplantation of the RPE in AMD,” Progress in Retinal and Eye Research, vol. 26, no. 5, pp. 516–554, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. N. M. Bressler, J. C. Silva, S. B. Bressler, S. L. Fine, and W. R. Green, “Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration,” Retina, vol. 14, no. 2, pp. 130–142, 1994. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Ferrara, H.-P. Gerber, and J. LeCouter, “The biology of VEGF and its receptors,” Nature Medicine, vol. 9, no. 6, pp. 669–676, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kliffen, H. S. Sharma, C. M. Mooy, S. Kerkvliet, and P. T. V. M. de Jong, “Increased expression of angiogenic growth factors in age-related maculopathy,” British Journal of Ophthalmology, vol. 81, no. 2, pp. 154–162, 1997. View at Google Scholar · View at Scopus
  19. D. R. Lally, A. T. Gerstenblith, and C. D. Regillo, “Preferred therapies for neovascular age-related macular degeneration,” Current Opinion in Ophthalmology, vol. 23, no. 3, pp. 182–188, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Rofagha, R. B. Bhisitkul, D. S. Boyer, S. R. Sadda, and K. Zhang, “Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP),” Ophthalmology, vol. 120, no. 11, pp. 2292–2299, 2013. View at Publisher · View at Google Scholar
  21. U. Schraermeyer and S. Julien, “Effects of bevacizumab in retina and choroid after intravitreal injection into monkey eyes,” Expert Opinion on Biological Therapy, vol. 13, no. 2, pp. 157–167, 2013. View at Google Scholar
  22. T. S. Chang, N. M. Bressler, J. T. Fine, C. M. Dolan, J. Ward, and T. R. Klesert, “Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial,” Archives of Ophthalmology, vol. 125, no. 11, pp. 1460–1469, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Haller, “Current anti-vascular endothelial growth factor dosing regimens: benefits and burden,” Ophthalmology, vol. 120, no. 5, supplement, pp. S3–S7, 2013. View at Google Scholar
  24. J. A. Dixon, S. C. N. Oliver, J. L. Olson, and N. Mandava, “VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration,” Expert Opinion on Investigational Drugs, vol. 18, no. 10, pp. 1573–1580, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. P. K. Kaiser, “Emerging therapies for neovascular age-related macular degeneration: drugs in the pipeline,” Ophthalmology, vol. 120, no. 5, supplement, pp. S11–S15, 2013. View at Google Scholar
  26. J. A. Adams, K. L. Paiva, J. E. Munzenrider, J. W. Miller, and E. S. Gragoudas, “Proton beam therapy for age-related macular degeneration: development of a standard plan,” Medical Dosimetry, vol. 24, no. 4, pp. 233–238, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. P. T. Finger, Y. P. Gelman, A. M. Berson, and A. Szechter, “Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study,” British Journal of Ophthalmology, vol. 87, no. 12, pp. 1497–1503, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Sivagnanavel, J. R. Evans, Z. Ockrim, and V. Chong, “Radiotherapy for neovascular age-related macular degeneration,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD004004, 2004. View at Google Scholar · View at Scopus
  29. H. J. Zambarakji, A. M. Lane, E. Ezra et al., “Proton beam irradiation for neovascular age-related macular degeneration,” Ophthalmology, vol. 113, no. 11, pp. 2012–2019, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. M. P. Ávila, M. E. Farah, A. Santos, J. P. Duprat, B. W. Woodward, and J. Nau, “Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration,” British Journal of Ophthalmology, vol. 93, no. 3, pp. 305–309, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. M. P. Ávila, M. E. Farah, A. Santos et al., “Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to amd,” Retina, vol. 29, no. 2, pp. 157–169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Gertner, E. Chell, K.-H. Pan, S. Hansen, P. K. Kaiser, and D. M. Moshfeghi, “Stereotactic targeting and dose verification for age-related macular degeneration,” Medical Physics, vol. 37, no. 2, pp. 600–606, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. R. A. Silva, A. A. Moshfeghi, P. K. Kaiser, R. P. Singh, and D. M. Moshfeghi, “Radiation treatment for age-related macular degeneration,” Seminars in Ophthalmology, vol. 26, no. 3, pp. 121–130, 2011. View at Publisher · View at Google Scholar
  34. P. U. Dugel, J. D. Bebchuk, J. Nau et al., “Epimacular brachytherapy for neovascular age-related macular degeneration: a randomized, controlled trial (CABERNET),” Ophthalmology, vol. 120, no. 2, pp. 317–327, 2013. View at Google Scholar
  35. J. S. Heier, A. N. Antoszyk, P. R. Pavan et al., “Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study,” Ophthalmology, vol. 113, no. 4, pp. 633.e1–633.e4, 2006. View at Google Scholar
  36. L. J. Hernandez-Pastor, A. Ortega, A. Garcia-Layana, and J. Giraldez, “Ranibizumab for neovascular age-related macular degeneration,” American Journal of Health-System Pharmacy, vol. 65, no. 19, pp. 1805–1814, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. P. J. Rosenfeld, D. M. Brown, J. S. Heier et al., “Ranibizumab for neovascular age-related macular degeneration,” The New England Journal of Medicine, vol. 355, no. 14, pp. 1419–1431, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Schmitz-Valckenberg, M. Fleckenstein, H.-M. Helb, P. C. Issa, H. P. N. Scholl, and F. G. Holz, “In vivo imaging of foveal sparing in geographic atrophy secondary to age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 50, no. 8, pp. 3915–3921, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Thumann, A. K. Salz, P. Walter, and S. Johnen, “Preservation of photoreceptors in dystrophic RCS rats following allo- and xenotransplantation of IPE cells,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 247, no. 3, pp. 363–369, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Thumann, A. Viethen, A. Gaebler et al., “The in vitro and in vivo behaviour of retinal pigment epithelial cells cultured on ultrathin collagen membranes,” Biomaterials, vol. 30, no. 3, pp. 287–294, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. “A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9,” Archives of Ophthalmology, vol. 119, no. 10, pp. 1439–1452, 2001.
  42. R. Klingel, C. Fassbender, I. Fischer et al., “Rheopheresis for age-related macular degeneration: a novel indication for therapeutic apheresis in ophthalmology,” Therapeutic Apheresis, vol. 6, no. 4, pp. 271–281, 2002. View at Google Scholar · View at Scopus
  43. J. S. Pulido, W. B. Anderson Jr., J. T. Flynn, P. R. Lichter, and D. Sanders, “Multicenter prospective, randomized, double-masked, placebo-controlled study of rheopheresis to treat nonexudative age-related macular degeneration: interim analysis,” Transactions of the American Ophthalmological Society, vol. 100, pp. 85–107, 2002. View at Google Scholar · View at Scopus
  44. J. S. Pulido, D. Sanders, and R. Klingel, “Rheopheresis for age-related macular degeneration: clinical results and putative mechanism of action,” Canadian Journal of Ophthalmology, vol. 40, no. 3, pp. 332–340, 2005. View at Google Scholar · View at Scopus
  45. T. R. Friberg, “Laser photocoagulation of eyes with drusen: will it help,” Seminars in Ophthalmology, vol. 14, no. 1, pp. 45–50, 1999. View at Google Scholar · View at Scopus
  46. T. R. Friberg, D. C. Musch, J. I. Lim, L. Morse, W. Freeman, and S. Sinclair, “Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients,” Ophthalmology, vol. 113, no. 4, pp. 612–622, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. L. da Cruz, F. K. Chen, A. Ahmado, J. Greenwood, and P. Coffey, “RPE transplantation and its role in retinal disease,” Progress in Retinal and Eye Research, vol. 26, no. 6, pp. 598–635, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. E. de Juan Jr., A. Loewenstein, N. M. Bressler, and J. Alexander, “Translocation of the retina for management of subfoveal choroidal neovascularization II: a preliminary report in humans,” American Journal of Ophthalmology, vol. 125, no. 5, pp. 635–646, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. J. C. Lai, D. J. Lapolice, S. S. Stinnett et al., “Visual outcomes following macular translocation with 360° peripheral retinectomy,” Archives of Ophthalmology, vol. 120, no. 10, pp. 1317–1324, 2002. View at Google Scholar · View at Scopus
  50. R. Machemer and U. H. Steinhorst, “Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration?” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 231, no. 11, pp. 635–641, 1993. View at Publisher · View at Google Scholar · View at Scopus
  51. F. Gelisken, M. Voelker, R. Schwabe et al., “Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT),” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 245, no. 8, pp. 1085–1095, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Binder, I. Krebs, R.-D. Hilgers et al., “Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial,” Investigative Ophthalmology and Visual Science, vol. 45, no. 11, pp. 4151–4160, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. C. I. Falkner-Radler, I. Krebs, C. Glittenberg et al., “Human retinal pigment epithelium (RPE) transplantation: outcome after autologous RPE-choroid sheet and RPE cell-suspension in a randomised clinical study,” British Journal of Ophthalmology, vol. 95, no. 3, pp. 370–375, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. A. M. Joussen, “How complete is successful? “Autologous retinal pigment epithelium and choriod translocation in patients with exsudative age-related macular degeneration: a short-term follow-up” by Jan van Meurs and P.R. van Biesen,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 241, no. 12, pp. 966–967, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. A. M. Joussen, F. M. A. Heussen, S. Joeres et al., “Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration,” American Journal of Ophthalmology, vol. 142, no. 1, pp. 17–30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. R. E. MacLaren, G. S. Uppal, K. S. Balaggan et al., “Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration,” Ophthalmology, vol. 114, no. 3, pp. 561–570, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. G. A. Peyman, K. J. Blinder, C. L. Paris, W. Alturki, N. C. Nelson Jr., and U. Desai, “A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring,” Ophthalmic Surgery, vol. 22, no. 2, pp. 102–108, 1991. View at Google Scholar · View at Scopus
  58. A. J. Carr, M. J. Smart, C. M. Ramsden, M. B. Powner, L. da Cruz, and P. J. Coffey, “Development of human embryonic stem cell therapies for age-related macular degeneration,” Trends in Neurosciences, vol. 36, no. 7, pp. 385–395, 2013. View at Publisher · View at Google Scholar
  59. M. Desai, L. A. Pratt, H. Lentzner, and K. N. Robinson, “Trends in vision and hearing among older Americans,” Aging Trends, no. 2, pp. 1–8, 2001. View at Google Scholar · View at Scopus
  60. L. Verma, T. Das, S. Binder et al., “New approaches in the management of choroidal neovascular membrane in age-related macular degeneration,” Indian Journal of Ophthalmology, vol. 48, no. 4, pp. 263–278, 2000. View at Google Scholar · View at Scopus
  61. P. Dargent-Molina, F. Favier, H. Grandjean et al., “Fall-related factors and risk of hip fracture: the EPIDOS prospective study,” The Lancet, vol. 348, no. 9021, pp. 145–149, 1996. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Q. Ivers, R. G. Cumming, P. Mitchell, and K. Attebo, “Visual impairment and falls in older adults: the blue mountains eye study,” Journal of the American Geriatrics Society, vol. 46, no. 1, pp. 58–64, 1998. View at Google Scholar · View at Scopus
  63. H. K. M. Lee and R. J. Scudds, “Comparison of balance in older people with and without visual impairment,” Age and Ageing, vol. 32, no. 6, pp. 643–649, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. A. F. Cruess, G. Zlateva, X. Xu et al., “Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study,” PharmacoEconomics, vol. 26, no. 1, pp. 57–73, 2008. View at Google Scholar · View at Scopus
  65. R. A. Williams, B. L. Brody, R. G. Thomas, R. M. Kaplan, and S. I. Brown, “The psychosocial impact of macular degeneration,” Archives of Ophthalmology, vol. 116, no. 4, pp. 514–520, 1998. View at Google Scholar · View at Scopus
  66. “Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group,” Archives of Ophthalmology, vol. 109, no. 9, pp. 1232–1241, 1991. View at Scopus
  67. G. Brown and M. M. Brown, “Let us wake the nation on the treatment for age-related macular degeneration,” Current Opinion in Ophthalmology, vol. 21, no. 3, pp. 169–171, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. M. M. Brown, G. C. Brown, J. D. Stein, Z. Roth, J. Campanella, and G. R. Beauchamp, “Age-related macular degeneration: economic burden and value-based medicine analysis,” Canadian Journal of Ophthalmology, vol. 40, no. 3, pp. 277–287, 2005. View at Google Scholar · View at Scopus
  69. A. Oishi, M. Mandai, A. Nishida, M. Hata, T. Matsuki, and Y. Kurimoto, “Remission and dropout rate of anti-VEGF therapy for age-related macular degeneration,” European Journal of Ophthalmology, vol. 21, no. 6, pp. 777–782, 2011. View at Publisher · View at Google Scholar
  70. A. Tufail, P. J. Patel, C. Egan et al., “Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study,” British Medical Journal, vol. 340, article c2459, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Sharma and A. Oliver-Fernandez, “Age-related macular degeneration and quality of life: how to interpret a research paper in health-related quality of life,” Current Opinion in Ophthalmology, vol. 15, no. 3, pp. 227–231, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Bonastre, C. le Pen, G. Soubrane, and G. Quentel, “The burden of age-related macular degeneration: results of a cohort study in two french referral centres,” PharmacoEconomics, vol. 21, no. 3, pp. 181–190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Cruess, G. Zlateva, X. Xu, and S. Rochon, “Burden of illness of neovascular age-related macular degeneration in Canada,” Canadian Journal of Ophthalmology, vol. 42, no. 6, pp. 836–843, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. R. Lopez, P. Gouras, M. Brittis, and H. Kjeldbye, “Transplantation of cultured rabbit retinal epithelium to rabbit retina using a closed-eye method,” Investigative Ophthalmology and Visual Science, vol. 28, no. 7, pp. 1131–1137, 1987. View at Google Scholar · View at Scopus
  75. S. Arnhold, P. Heiduschka, H. Klein et al., “Adenovirally transduced bone marrow stromal cells differentiate into pigment epithelial cells and induce rescue effects in RCS rats,” Investigative Ophthalmology and Visual Science, vol. 47, no. 9, pp. 4121–4129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. P. J. Coffey, S. Girman, S. M. Wang et al., “Long-term preservation of cortically dependent visual function in RCS rats by transplantation,” Nature Neuroscience, vol. 5, no. 1, pp. 53–56, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. C. Gias, M. Jones, D. Keegan et al., “Preservation of visual cortical function following retinal pigment epithelium transplantation in the RCS rat using optical imaging techniques,” European Journal of Neuroscience, vol. 25, no. 7, pp. 1940–1948, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Gouras, J. Kong, and S. H. Tsang, “Retinal degeneration and RPE transplantation in RPE65−/− mice,” Investigative Ophthalmology and Visual Science, vol. 43, no. 10, pp. 3307–3311, 2002. View at Google Scholar · View at Scopus
  79. B. Lu, C. Malcuit, S. Wang et al., “Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration,” Stem Cells, vol. 27, no. 9, pp. 2126–2135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. R. D. Lund, S. Wang, I. Klimanskaya et al., “Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats,” Cloning and Stem Cells, vol. 8, no. 3, pp. 189–199, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. I. Semkova, F. Kreppel, G. Welsandt et al., “Autologous transplantation of genetically modified iris pigment epithelial cells: a promising concept for the treatment of age-related macular degeneration and other disorders of the eye,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 20, pp. 13090–13095, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. S. Wang, B. Lu, S. Girman, T. Holmes, N. Bischoff, and R. D. Lund, “Morphological and functional rescue in RCS rats after RPE cell line transplantation at a later stage of degeneration,” Investigative Ophthalmology and Visual Science, vol. 49, no. 1, pp. 416–421, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. P. V. Algvere, L. Berglin, P. Gouras, Y. Sheng, and E. D. Kopp, “Transplantation of RPE in age-related macular degeneration: observations in disciform lesions and dry RPE atrophy,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 235, no. 3, pp. 149–158, 1997. View at Publisher · View at Google Scholar · View at Scopus
  84. Z. Ma, L. Han, C. Wang et al., “Autologous transplantation of retinal pigment epithelium-Bruch's membrane complex for hemorrhagic age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 50, no. 6, pp. 2975–2981, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. T. Abe, M. Yoshida, H. Tomita et al., “Functional analysis after auto iris pigment epithelial cell transplantation in patients with age-related macular degeneration,” Tohoku Journal of Experimental Medicine, vol. 189, no. 4, pp. 295–305, 1999. View at Google Scholar · View at Scopus
  86. T. Abe, M. Yoshida, Y. Yoshioka et al., “Iris pigment epithelial cell transplantation for degenerative retinal diseases,” Progress in Retinal and Eye Research, vol. 26, no. 3, pp. 302–321, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Aisenbrey, B. A. Lafaut, P. Szurman et al., “Iris pigment epithelial translocation in the treatment of exudative macular degeneration: a 3-year follow-up,” Archives of Ophthalmology, vol. 124, no. 2, pp. 183–188, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. S. D. Schwartz, J.-P. Hubschman, G. Heilwell et al., “Embryonic stem cell trials for macular degeneration: a preliminary report,” The Lancet, vol. 379, no. 9817, pp. 713–720, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Arnhold, I. Semkova, C. Andressen et al., “Iris pigment epithelial cells: a possible cell source for the future treatment of neurodegenerative diseases,” Experimental Neurology, vol. 187, no. 2, pp. 410–417, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. G. Thumann, K. U. Bartz-Schmidt, K. Heimann, and U. Schraermeyer, “Phagocytosis of rod outer segments by human iris pigment epithelial cells in vitro,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 236, no. 10, pp. 753–757, 1998. View at Publisher · View at Google Scholar · View at Scopus
  91. G. Thumann, N. Kociok, K. U. Bartz-Schmidt, P. Esser, U. Schraermeyer, and K. Heimann, “Detection of mRNA for proteins involved in retinol metabolism in iris pigment epithelium,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 237, no. 12, pp. 1046–1051, 1999. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Crafoord, L. Geng, S. Seregard, and P. V. Algvere, “Photoreceptor survival in transplantation of autologous iris pigment epithelial cells to the subretinal space,” Acta Ophthalmologica Scandinavica, vol. 80, no. 4, pp. 387–394, 2002. View at Publisher · View at Google Scholar · View at Scopus
  93. G. Thumann, K. U. Bartz-Schmidt, H. El Bakri et al., “Transplantation of autologous iris pigment epithelium to the subretinal space in rabbits,” Transplantation, vol. 68, no. 2, pp. 195–201, 1999. View at Publisher · View at Google Scholar · View at Scopus
  94. I. A. Bhutto, D. S. McLeod, T. Hasegawa et al., “Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration,” Experimental Eye Research, vol. 82, no. 1, pp. 99–110, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. J.-P. Tong, W.-M. Chan, D. T. L. Liu et al., “Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization,” American Journal of Ophthalmology, vol. 141, no. 3, pp. 456–462, 2006. View at Publisher · View at Google Scholar · View at Scopus
  96. N. Ferrara, “Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications,” Seminars in Oncology, vol. 29, no. 6, supplement 16, pp. 10–14, 2002. View at Google Scholar · View at Scopus
  97. J. W. Miller, J. Le Couter, E. C. Strauss, and N. Ferrara, “Vascular endothelial growth factor a in intraocular vascular disease,” Ophthalmology, vol. 120, no. 1, pp. 106–114, 2013. View at Google Scholar
  98. N. Kwak, N. Okamoto, J. M. Wood, and P. A. Campochiaro, “VEGF is major stimulator in model of choroidal neovascularization,” Investigative Ophthalmology and Visual Science, vol. 41, no. 10, pp. 3158–3164, 2000. View at Google Scholar · View at Scopus
  99. K. Ohno-Matsui, “Molecular mechanism for choroidal neovascularization in age-related macular degeneration,” Nippon Ganka Gakkai Zasshi, vol. 107, no. 11, pp. 657–673, 2003. View at Google Scholar · View at Scopus
  100. M. E. Carwile, R. B. Culbert, R. L. Sturdivant, and T. W. Kraft, “Rod outer segment maintenance is enhanced in the presence of BFGF, CNTF and GDNF,” Experimental Eye Research, vol. 66, no. 6, pp. 791–805, 1998. View at Publisher · View at Google Scholar · View at Scopus
  101. M. M. LaVail, K. Unoki, D. Yasumura, M. T. Matthes, G. D. Yancopoulos, and R. H. Steinberg, “Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 23, pp. 11249–11253, 1992. View at Publisher · View at Google Scholar · View at Scopus
  102. K. Unoki and M. M. LaVail, “Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor,” Investigative Ophthalmology and Visual Science, vol. 35, no. 3, pp. 907–915, 1994. View at Google Scholar · View at Scopus
  103. N. H. V. Chong, R. A. Alexander, L. Waters, K. C. Barnett, A. C. Bird, and P. J. Luthert, “Repeated injections of a ciliary neurotrophic factor analogue leading to long-term photoreceptor survival in hereditary retinal degeneration,” Investigative Ophthalmology and Visual Science, vol. 40, no. 6, pp. 1298–1305, 1999. View at Google Scholar · View at Scopus
  104. C. J. Barnstable and J. Tombran-Tink, “Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential,” Progress in Retinal and Eye Research, vol. 23, no. 5, pp. 561–577, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. D. W. Dawson, O. V. Volpert, P. Gillis et al., “Pigment epithelium-derived factor: a potent inhibitor of angiogenesis,” Science, vol. 285, no. 5425, pp. 245–248, 1999. View at Publisher · View at Google Scholar · View at Scopus
  106. N. Kociok and A. M. Joussen, “Varied expression of functionally important genes of RPE and choroid in the macula and in the periphery of normal human eyes,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 245, no. 1, pp. 101–113, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. P. Kozulin, R. Natoli, K. M. B. O'Brien, M. C. Madigan, and J. M. Provis, “The cellular expression of antiangiogenic factors in fetal primate macula,” Investigative Ophthalmology and Visual Science, vol. 51, no. 8, pp. 4298–4306, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. I. A. Bhutto, S. Y. Kim, D. S. McLeod et al., “Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 45, no. 5, pp. 1544–1552, 2004. View at Publisher · View at Google Scholar · View at Scopus
  109. I. A. Bhutto, K. Uno, C. Merges, L. Zhang, D. S. McLeod, and G. A. Lutty, “Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration,” Archives of Ophthalmology, vol. 126, no. 5, pp. 670–678, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. N. M. Holekamp, N. Bouck, and O. Volpert, “Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration,” American Journal of Ophthalmology, vol. 134, no. 2, pp. 220–227, 2002. View at Publisher · View at Google Scholar · View at Scopus
  111. N. Ogata, M. Wada, T. Otsuji, N. Jo, J. Tombran-Tink, and M. Matsumura, “Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization,” Investigative Ophthalmology and Visual Science, vol. 43, no. 4, pp. 1168–1175, 2002. View at Google Scholar · View at Scopus
  112. J. Spranger, M. Osterhoff, M. Reimann et al., “Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease,” Diabetes, vol. 50, no. 12, pp. 2641–2645, 2001. View at Google Scholar · View at Scopus
  113. S. Lee, S. J. Song, and H. G. Yu, “Current smoking is associated with a poor visual acuity improvement after intravitreal ranibizumab therapy in patients with exudative age-related macular degeneration,” Journal of Korean Medical Science, vol. 28, no. 5, pp. 769–774, 2013. View at Google Scholar
  114. M. Pons and M. E. Marin-Castaño, “Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD,” Investigative Ophthalmology & Visual Science, vol. 52, no. 6, pp. 3842–3853, 2011. View at Google Scholar · View at Scopus
  115. D. M. Brown, M. Michels, P. K. Kaiser, J. S. Heier, J. P. Sy, and T. Ianchulev, “Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study,” Ophthalmology, vol. 116, no. 1, pp. 57–65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. D. F. Martin, M. G. Maguire, G.-S. Ying, J. E. Grunwald, S. L. Fine, and G. J. Jaffe, “Ranibizumab and bevacizumab for neovascular age-related macular degeneration,” The New England Journal of Medicine, vol. 364, no. 20, pp. 1897–1908, 2011. View at Publisher · View at Google Scholar · View at Scopus
  117. R. A. Adelman, Q. Zheng, and H. R. Mayer, “Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections,” Journal of Ocular Pharmacology and Therapeutics, vol. 26, no. 1, pp. 105–110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  118. R. Krishnan, S. Goverdhan, and J. Lochhead, “Submacular haemorrhage after intravitreal bevacizumab compared with intravitreal ranibizumab in large occult choroidal neovascularization,” Clinical and Experimental Ophthalmology, vol. 37, no. 4, pp. 384–388, 2009. View at Publisher · View at Google Scholar · View at Scopus
  119. V. K. Gullapalli, I. K. Sugino, Y. van Patten, S. Shah, and M. A. Zarbin, “Impaired RPE survival on aged submacular human Bruch's membrane,” Experimental Eye Research, vol. 80, no. 2, pp. 235–248, 2005. View at Publisher · View at Google Scholar · View at Scopus
  120. A. A. Hussain, Y. Lee, J.-J. Zhang, and J. Marshall, “Disturbed matrix metalloproteinase activity of Bruch's membrane in age-related macular degeneration,” Investigative Ophthalmology & Visual Science, vol. 52, no. 7, pp. 4459–4466, 2011. View at Google Scholar · View at Scopus
  121. A. A. Hussain, C. Starita, A. Hodgetts, and J. Marshall, “Macromolecular diffusion characteristics of ageing human Bruch's membrane: implications for age-related macular degeneration (AMD),” Experimental Eye Research, vol. 90, no. 6, pp. 703–710, 2010. View at Publisher · View at Google Scholar · View at Scopus
  122. I. K. Sugino, Q. Sun, J. Wang et al., “Comparison of FRPE and human embryonic stem cell-derived rpe behavior on aged human Bruch's membrane,” Investigative Ophthalmology and Visual Science, vol. 52, no. 8, pp. 4979–4997, 2011. View at Publisher · View at Google Scholar · View at Scopus
  123. X. Yuan, X. Gu, J. S. Crabb et al., “Quantitative proteomics: comparison of the macular Bruch membrane/choroid complex from age-related macular degeneration and normal eyes,” Molecular and Cellular Proteomics, vol. 9, no. 6, pp. 1031–1046, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. S. R. Hynes and E. B. Lavik, “A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 248, no. 6, pp. 763–778, 2010. View at Publisher · View at Google Scholar · View at Scopus
  125. B. V. Stanzel, Z. Liu, R. Brinken, N. Braun, F. G. Holz, and N. Eter, “Subretinal delivery of ultrathin rigid-elastic cell carriers using a metallic shooter instrument and biodegradable hydrogel encapsulation,” Investigative Ophthalmology & Visual Science, vol. 53, no. 1, pp. 490–500, 2012. View at Google Scholar · View at Scopus
  126. H. A. J. Thomson, A. J. Treharne, P. Walker, M. C. Grossel, and A. J. Lotery, “Optimisation of polymer scaffolds for retinal pigment epithelium (RPE) cell transplantation,” British Journal of Ophthalmology, vol. 95, no. 4, pp. 563–568, 2011. View at Publisher · View at Google Scholar · View at Scopus
  127. U. Bartsch, W. Oriyakhel, P. F. Kenna et al., “Retinal cells integrate into the outer nuclear layer and differentiate into mature photoreceptors after subretinal transplantation into adult mice,” Experimental Eye Research, vol. 86, no. 4, pp. 691–700, 2008. View at Publisher · View at Google Scholar · View at Scopus
  128. M. del Cerro, M. F. D. Notter, C. del Cerro, S. J. Wiegand, D. A. Grover, and E. Lazar, “Intraretinal transplantation for rod-cell replacement in light-damaged retinas,” Journal of Neural Transplantation, vol. 1, no. 1, pp. 1–10, 1989. View at Google Scholar · View at Scopus
  129. A. S. L. Kwan, S. Wang, and R. D. Lund, “Photoreceptor layer reconstruction in a rodent model of retinal degeneration,” Experimental Neurology, vol. 159, no. 1, pp. 21–33, 1999. View at Publisher · View at Google Scholar · View at Scopus
  130. I. Grabundzija, J. Wang, A. Sebe et al., “Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells,” Nucleic Acids Research, vol. 41, no. 3, pp. 1829–1847, 2013. View at Google Scholar
  131. Z. B. Jin, S. Okamoto, P. Xiang, and M. Takahashi, “Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling,” Stem Cells Translational Medicine, vol. 1, no. 6, pp. 503–509, 2012. View at Google Scholar
  132. D. E. Buchholz, B. O. Pennington, R. H. Croze, C. R. Hinman, P. J. Coffey, and D. O. Clegg, “Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium,” Stem Cells Translational Medicine, vol. 2, no. 5, pp. 384–393, 2013. View at Publisher · View at Google Scholar
  133. J. Maruotti, K. Wahlin, D. Gorrell, I. Bhutto, G. Lutty, and D. J. Zack, “A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells,” Stem Cells Translational Medicine, vol. 2, no. 5, pp. 341–354, 2013. View at Publisher · View at Google Scholar
  134. H. Melville, M. Carpiniello, K. Hollis, A. Staffaroni, and N. Golestaneh, “Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration,” Journal of Translational Medicine, vol. 11, article 53, 2013. View at Publisher · View at Google Scholar
  135. G. A. Moviglia, G. A. Moviglia, N. Blasetti, J. O. Zarate, and D. E. Pelayes, “In vitro differentiation of adult adipose mesenchymal stem cells into retinal progenitor cells,” Ophthalmic Research, vol. 48, supplement 1, pp. 1–5, 2012. View at Google Scholar
  136. S. R. Mekala, V. Vauhini, U. Nagarajan, S. Maddileti, S. Gaddipati, and I. Mariappan, “Derivation, characterization and retinal differentiation of induced pluripotent stem cells,” Journal of Biosciences, vol. 38, no. 1, pp. 123–134, 2013. View at Google Scholar
  137. D. A. Lamba, A. McUsic, R. K. Hirata, P.-R. Wang, D. Russell, and T. A. Reh, “Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells,” PLoS ONE, vol. 5, no. 1, Article ID e8763, 2010. View at Publisher · View at Google Scholar · View at Scopus
  138. R. E. MacLaren, R. A. Pearson, A. MacNeil et al., “Retinal repair by transplantation of photoreceptor precursors,” Nature, vol. 444, no. 7116, pp. 203–207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  139. A. M. Geurts, C. S. Hackett, J. B. Bell et al., “Structure-based prediction of insertion-site preferences of transposons into chromosomes,” Nucleic Acids Research, vol. 34, no. 9, pp. 2803–2811, 2006. View at Publisher · View at Google Scholar · View at Scopus
  140. Z. Ivics, P. B. Hackett, R. H. Plasterk, and Z. Izsvák, “Molecular reconstruction of sleeping beauty, a Tc1-like transposon from fish, and its transposition in human cells,” Cell, vol. 91, no. 4, pp. 501–510, 1997. View at Google Scholar · View at Scopus
  141. Z. Izsvák, P. B. Hackett, L. J. N. Cooper, and Z. Ivics, “Translating Sleeping Beauty transposition into cellular therapies: victories and challenges,” BioEssays, vol. 32, no. 9, pp. 756–767, 2010. View at Publisher · View at Google Scholar · View at Scopus
  142. L. Mátés, M. K. L. Chuah, E. Belay et al., “Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates,” Nature Genetics, vol. 41, no. 6, pp. 753–761, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. C. Sheridan, R. Williams, and I. Grierson, “Basement membranes and artificial substrates in cell transplantation,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 242, no. 1, pp. 68–75, 2004. View at Publisher · View at Google Scholar · View at Scopus
  144. T. H. Tezel, H. J. Kaplan, and L. V. del Priore, “Fate of human retinal pigment epithelial cells seeded onto layers of human Bruch's membrane,” Investigative Ophthalmology and Visual Science, vol. 40, no. 2, pp. 467–476, 1999. View at Google Scholar · View at Scopus
  145. A. A. Castellarin, I. K. Sugino, J. A. Vargas, B. Parolini, G. M. Lui, and M. A. Zarbin, “In vitro transplantation of fetal human retinal pigment epithelial cells onto human cadaver Bruch's membrane,” Experimental Eye Research, vol. 66, no. 1, pp. 49–67, 1998. View at Publisher · View at Google Scholar · View at Scopus
  146. G. Thumann, U. Schraermeyer, K. U. Bartz-Schmidt, and K. Heimann, “Descemet's membrane as membranous support in RPE/IPE transplantation,” Current Eye Research, vol. 16, no. 12, pp. 1236–1238, 1997. View at Google Scholar · View at Scopus
  147. J. F. Kiilgaard, A. K. Wiencke, E. Scherfig, J. U. Prause, and M. La Cour, “Transplantation of allogenic anterior lens capsule to the subretinal space in pigs,” Acta Ophthalmologica Scandinavica, vol. 80, no. 1, pp. 76–81, 2002. View at Publisher · View at Google Scholar · View at Scopus
  148. C. Capeéans, A. Piñeiro Ces, M. Pardo et al., “Amniotic membrane as support for human retinal pigment epithelium (RPE) cell growth,” Acta Ophthalmologica Scandinavica, vol. 81, no. 3, pp. 271–277, 2003. View at Publisher · View at Google Scholar · View at Scopus
  149. B. V. Stanzel, E. M. Espana, M. Grueterich et al., “Amniotic membrane maintains the phenotype of rabbit retinal pigment epithelial cells in culture,” Experimental Eye Research, vol. 80, no. 1, pp. 103–112, 2005. View at Publisher · View at Google Scholar · View at Scopus
  150. A. Fung, C. J. Lee, T. Leng et al., “Tissue engineered lens capsule as a substrate for IPE and RPE transplantation,” Investigative Ophthalmology & Visual Science, vol. 43, no. 12, 2002, E-abstract 3452. View at Google Scholar
  151. S. Nadri, S. Yazdani, E. Arefian et al., “Mesenchymal stem cells from trabecular meshwork become photoreceptor-like cells on amniotic membrane,” Neuroscience Letters, vol. 541, pp. 43–48, 2013. View at Google Scholar
  152. E. B. Lavik, H. Klassen, K. Warfvinge, R. Langer, and M. J. Young, “Fabrication of degradable polymer scaffolds to direct the integration and differentiation of retinal progenitors,” Biomaterials, vol. 26, no. 16, pp. 3187–3196, 2005. View at Publisher · View at Google Scholar · View at Scopus
  153. J. Yao, S. L. Tao, and M. J. Young, “Synthetic polymer scaffolds for stem cell transplantation in retinal tissue engineering,” Polymers, vol. 3, no. 2, pp. 899–914, 2011. View at Publisher · View at Google Scholar · View at Scopus
  154. W. L. Neeley, S. Redenti, H. Klassen et al., “A microfabricated scaffold for retinal progenitor cell grafting,” Biomaterials, vol. 29, no. 4, pp. 418–426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  155. S. Redenti, S. Tao, J. Yang et al., “Retinal tissue engineering using mouse retinal progenitor cells and a novel biodegradable, thin-film poly(e-caprolactone) nanowire scaffold,” Journal of Ocular Biology, Diseases, and Informatics, vol. 1, no. 1, pp. 19–29, 2008. View at Publisher · View at Google Scholar · View at Scopus
  156. S. Tao, C. Young, S. Redenti et al., “Survival, migration and differentiation of retinal progenitor cells transplanted on micro-machined poly(methyl methacrylate) scaffolds to the subretinal space,” Lab on a Chip, vol. 7, no. 6, pp. 695–701, 2007. View at Publisher · View at Google Scholar · View at Scopus
  157. J. F. Mano, G. A. Silva, H. S. Azevedo et al., “Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends,” Journal of the Royal Society Interface, vol. 4, no. 17, pp. 999–1030, 2007. View at Publisher · View at Google Scholar · View at Scopus
  158. M. A. Alamein, S. Stephens, Q. Liu, S. Skabo, and P. H. Warnke, “Mass production of nanofibrous extracellular matrix with controlled 3D morphology for large-scale soft tissue regeneration,” Tissue Engineering C, vol. 19, no. 6, pp. 458–472, 2013. View at Google Scholar
  159. C. Vaquette and J. J. Cooper-White, “Increasing electrospun scaffold pore size with tailored collectors for improved cell penetration,” Acta Biomaterialia, vol. 7, no. 6, pp. 2544–2557, 2011. View at Publisher · View at Google Scholar · View at Scopus
  160. T. D. Brown, P. D. Dalton, and D. W. Hutmacher, “Direct writing by way of melt electrospinning,” Advanced Materials, vol. 23, no. 47, pp. 5651–5657, 2011. View at Publisher · View at Google Scholar · View at Scopus
  161. C. Wei and J. Dong, “Direct fabrication of high-resolution three-dimensional polymeric scaffolds using electrohydrodynamic hot jet plotting,” Journal of Micromechanics and Microengineering, vol. 23, no. 2, Article ID 025017, 2013. View at Google Scholar
  162. M. R. Steedman, S. L. Tao, H. Klassen, and T. A. Desai, “Enhanced differentiation of retinal progenitor cells using microfabricated topographical cues,” Biomedical Microdevices, vol. 12, no. 3, pp. 363–369, 2010. View at Publisher · View at Google Scholar · View at Scopus
  163. A. C. McUsic, D. A. Lamba, and T. A. Reh, “Guiding the morphogenesis of dissociated newborn mouse retinal cells and hES cell-derived retinal cells by soft lithography-patterned microchannel PLGA scaffolds,” Biomaterials, vol. 33, no. 5, pp. 1396–1405, 2012. View at Publisher · View at Google Scholar · View at Scopus
  164. T. H. Tezel, L. V. del Priore, and H. J. Kaplan, “Reengineering of aged Bruch's membrane to enhance retinal pigment epithelium repopulation,” Investigative Ophthalmology and Visual Science, vol. 45, no. 9, pp. 3337–3348, 2004. View at Publisher · View at Google Scholar · View at Scopus
  165. U. Hersel, C. Dahmen, and H. Kessler, “RGD modified polymers: biomaterials for stimulated cell adhesion and beyond,” Biomaterials, vol. 24, no. 24, pp. 4385–4415, 2003. View at Publisher · View at Google Scholar · View at Scopus
  166. A. J. Treharne, H. A. Thomson, M. C. Grossel, and A. J. Lotery, “Developing methacrylate-based copolymers as an artificial Bruch's membrane substitute,” Journal of Biomedical Materials Research A, vol. 100, no. 9, pp. 2358–2364, 2012. View at Google Scholar
  167. R. Sistiabudi, J. Paderi, A. Panitch, and A. Ivanisevic, “Modification of native collagen with cell-adhesive peptide to promote RPE cell attachment on Bruch's membrane,” Biotechnology and Bioengineering, vol. 102, no. 6, pp. 1723–1729, 2009. View at Publisher · View at Google Scholar · View at Scopus
  168. D. Grafahrend, K.-H. Heffels, M. V. Beer et al., “Degradable polyester scaffolds with controlled surface chemistry combining minimal protein adsorption with specific bioactivation,” Nature Materials, vol. 10, no. 1, pp. 67–73, 2011. View at Publisher · View at Google Scholar · View at Scopus
  169. M. Bartneck, K.-H. Heffels, Y. Pan, M. Bovi, G. Zwadlo-Klarwasser, and J. Groll, “Inducing healing-like human primary macrophage phenotypes by 3D hydrogel coated nanofibres,” Biomaterials, vol. 33, no. 16, pp. 4136–4146, 2012. View at Publisher · View at Google Scholar · View at Scopus
  170. D. Grafahrend, K.-H. Heffels, M. Möller, D. Klee, and J. Groll, “Electrospun, biofunctionalized fibers as tailored in vitro substrates for keratinocyte cell culture,” Macromolecular Bioscience, vol. 10, no. 9, pp. 1022–1027, 2010. View at Publisher · View at Google Scholar · View at Scopus